Katrina Laughton - Concepedia

Concepedia

Author

Katrina Laughton

The University of Melbourne

Also Known As

K Laughton, K. Laughton, Katrina Laughton, Katrina M Laughton, Katrina M. Laughton, Katrina M. Laughton

42

Publications

3.3K

Citations

23

H-Index

77

Concepts

All Affiliations

The University of Melbourne Mental Health Research Institute The Alfred Hospital Florey Institute of Neuroscience and Mental Health Austin Health

KL

About

Katrina Laughton is an author at The University of Melbourne specializing in medicine, neurodegenerative diseases, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	2.2K
2	Social Sciences	5	5	987
3	Natural Sciences	3	3	648
4	Health Sciences	1	1	45
5	Allergy	1	1	100

Katrina Laughton

×

25

Publications

3.3K

Citations

23

H-Index

	Year	Citations
Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ Paul A. Adlard, Robert A. Cherny, David I. Finkelstein, Neuron Neurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceMedicineSynaptic Transmission	2008	657
Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau Simon Melov, Paul A. Adlard, Karl Morten, PLoS ONE	2007	355
Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity Anthony R. White, Tai Du, Katrina Laughton, Journal of Biological Chemistry Metalloprotease ActivityNeurodegenerative DiseasesAlzheimer Disease AmyloidAlzheimer's DiseaseBiochemistry	2006	281
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation Peter J. Crouch, Lin W. Hung, Paul A. Adlard, Proceedings of the National Academy of Sciences Neurodegenerative DiseasesCognitive DeclineAlzheimer's DiseaseTau PhosphorylationBiochemistry	2009	263
Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide Paul S. Donnelly, Aphrodite Caragounis, Tai Du, Journal of Biological Chemistry Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryComplexes Reduces LevelsAlzheimer Disease Therapy	2007	191
<i>In Vitro</i>Characterization of Pittsburgh Compound-B Binding to Lewy Bodies Michelle T. Fodero‐Tavoletti, David P. Smith, Catriona McLean, Journal of Neuroscience	2007	159
Plasma α-synuclein is decreased in subjects with Parkinson's disease Qiao‐Xin Li, Su San Mok, Katrina Laughton, Experimental Neurology Neurodegenerative DiseasesNeurobiology Of DiseaseDegenerative DiseasesParkinson DiseaseDegenerative Disease	2006	154
Acute phase protein and cytokine levels in serum and saliva: A comparison of detectable levels and correlations in a depressed and healthy adolescent sample Michelle L. Byrne, Neil M. O’Brien‐Simpson, Eric C. Reynolds, Brain Behavior and Immunity Cytokine LevelsPsychoneuroimmunologyPsychiatryMood SymptomHealthy Adolescent Sample	2013	144
Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging James Lui, Simon M. Laws, Qiao‐Xin Li, Journal of Alzheimer s Disease	2010	132
Copper Promotes the Trafficking of the Amyloid Precursor Protein Karla Acevedo, Ya Hui Hung, Andrew Dalziel, Journal of Biological Chemistry Molecular BiologyNeurochemical BiomarkersAmyloid Precursor ProteinSynaptic SignalingAlzheimer's Disease	2010	104

Page 1